Guidelines are suggested for the surveillance and prevention of ototoxicity in adults, based on experience and a compilation of opinions from otolaryngologists and infectious disease specialists. The influence of dosage and renal function on serum levels and their relevance to ototoxicity are discussed. Indications for testing of inner ear function are considered.
Get full access to this article
View all access options for this article.
References
1.
GreenwoodGJ: Neomycin ototoxicity: Report of a case. Arch Otolaryngol69: 390–397, 1959.
2.
AppelGB, NeuHC: The nephrotoxicity of antimicrobial agents. N Engl J Med296: 722–728, 1977.
3.
KohonenA, TarkkanenJ: Cochlear damage from ototoxic antibiotics by intratympanic application. Acta Otolaryngol68: 90–97, 1969.
4.
HelmWH: Ototoxicity of neomycin aerosol. Lancet1:1294, 1960.
5.
DaviaJE, SiemsenAW, AndersonRW: Uremia, deafness, and paralysis due to irrigating antibiotic solutions. Arch Intern Med125: 135–139, 1970.
6.
KellyDR, NiloER, BerggrenRB: Deafness after topical neomycin wound irrigation. N Engl J Med280: 1338–1339, 1969.
7.
WardKM, RounthwaiteFJ: Neomycin ototoxicity. Ann Otol Rhinol Laryngol87: 211–215, 1978.
8.
WestBA, BrummettRE, HimesDL: Interaction of kanamycin and ethacrynic acid. Arch Otolaryngol98: 32–37, 1973.
9.
BrummettRE, TraynorJ, BrownR: Cochlear damage resulting from kanamycin and furosemide. Acta Otolaryngol80: 86–92, 1975.
10.
MatzGJ: Ototoxic effects of ethacrynic acid in man and animals. Laryngoscope86: 1065–1086, 1976.
11.
QuickCA, HoppeW: Permanent deafness associated with furosemide administration. Ann Otol Rhinol Laryngol84: 94–101, 1975.
12.
HawkinsJEJr., PrestonRE: Vestibular ototoxicity, in NauntonRF (ed): The Vestibular System. New York, Academic Press Inc, 1975, pp 321–348.
13.
NordstromL, BanckG, BelfrageS: Prospective study of the ototoxicity of gentamicin. Acta Pathol Microbiol Scand [B]241(suppl 81):58–61, 1973.
14.
LernerSA, SeligsohnR, MatzGJ: Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin. Am J Med62: 919–923, 1977.
15.
FinegoldSM: Toxicity of kanamycin in adults. Ann NY Acad Sci132: 942–956, 1966.
16.
LaneAZ, WrightGE, BlairDC: Ototoxicity and nephrotoxicity of amikacin: An overview of phase II and phase III experience in the United States. Am J Med62: 911–918, 1977.
17.
MatzGJ, LernerSA: Drug ototoxicity, in BeagleyHA (ed): Audiology and Audiologic Medicine. New York, Oxford University Press, to be published.
18.
TjernstromO, BanckG, BelfrageS: The ototoxicity of gentamicin. Acta Pathol Microbiol Scand [B]241(suppl 81):73–78, 1973.
19.
LehmannW, HauslerR, WaldvogelFA: A clinical study on the ototoxic effects of tobramycin. Arch Otorhinolaryngol (NY)212: 203–211, 1976.
